Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals

被引：49
|
作者：
Grunau, Brian [1 ]
Goldfarb, DavidM. [2 ]
Asamoah-Boaheng, Michael [3 ]
Golding, Liam [4 ]
Kirkham, Tracy L. [5 ]
Demers, Paul A. [5 ]
Lavoie, Pascal M. [6 ]
机构：
[1] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
[4] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 03期
关键词：
D O I：
10.1001/jama.2021.21921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 281
页数：3
相关论文
共 50 条
  • [41] Preclinical data from SARS-CoV-2 mRNA vaccine
    Vabret, Nicolas
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (8) : 461 - 461
  • [42] Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine
    Mccrudden, Cian M.
    Bennie, Lindsey
    Chambers, Philip
    Wilson, Jordan
    Kerr, Megan
    Ziminska, Monika
    Douglas, Hayley
    Kuhn, Sarah
    Carroll, Emma
    O'Brien, Garrett
    Buckley, Niamh
    Dunne, Nicholas J.
    Mccarthy, Helen O.
    JOURNAL OF CONTROLLED RELEASE, 2023, 362 : 536 - 547
  • [43] Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity
    D'Souza, Mathieu
    Keeshan, Alexa
    Gravel, Christopher A.
    Langlois, Marc-Andre
    Cooper, Curtis L.
    NPJ VACCINES, 2024, 9 (01)
  • [44] Immunogenicity and adverse events of SARS-CoV-2 vaccine in health workers
    Juarez, Vicente
    Marina, Gabriela
    Ramon, Claudia
    Parentis, Mariangeles
    Mamani, Lorena
    Rua, Gustavo A.
    Espindola, Maria E. Crespo
    Buschiazzo, Emilio a.
    Aciar, Mariana m.
    Belbruno, Leila n.
    Lecumberri, MARiA B.
    Ralle, Ana c.
    Murillo, Juan m. luna
    Delgado, Lucia
    Caceres, Ivanna miranda
    Bonnal, Juan p.
    Guzman, Valeria e.
    Eddelcop, Bernardo a.
    MEDICINA-BUENOS AIRES, 2024, 84 (03) : 496 - 504
  • [45] Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
    Kandeil, Ahmed
    Mostafa, Ahmed
    Hegazy, Rehab R.
    El-Shesheny, Rabeh
    El Taweel, Ahmed
    Gomaa, Mokhtar R.
    Shehata, Mahmoud
    Elbaset, Marawan A.
    Kayed, Ahmed E.
    Mahmoud, Sara H.
    Moatasim, Yassmin
    Kutkat, Omnia
    Yassen, Noha N.
    Shabana, Marwa E.
    GabAllah, Mohamed
    Kamel, Mina Nabil
    Abo Shama, Noura M.
    El Sayes, Mohamed
    Ahmed, Amira N.
    Elalfy, Zahraa S.
    Mohamed, Bassim M. S. A.
    Abd El-Fattah, Safa N.
    El Hariri, Hazem Mohamed
    Abdel Kader, Mona
    Azmy, Osama
    Kayali, Ghazi
    Ali, Mohamed A.
    VACCINES, 2021, 9 (03) : 1 - 15
  • [46] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
    Malard, Florent
    Gaugler, Beatrice
    Gozlan, Joel
    Bouquet, Lucie
    Fofana, Djeneba
    Siblany, Lama
    Eshagh, Deborah
    Adotevi, Olivier
    Laheurte, Caroline
    Ricard, Laure
    Dulery, Remy
    Stocker, Nicolas
    van de Wyngaert, Zoe
    Genthon, Alexis
    Banet, Anne
    Memoli, Mara
    Ikhlef, Souhila
    Sestilli, Simona
    Vekhof, Anne
    Brissot, Eolia
    Marjanovic, Zora
    Chantran, Yannick
    Cuervo, Nancy
    Ballot, Eric
    Morand-Joubert, Laurence
    Mohty, Mohamad
    BLOOD CANCER JOURNAL, 2021, 11 (08)
  • [47] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
    Florent Malard
    Béatrice Gaugler
    Joel Gozlan
    Lucie Bouquet
    Djeneba Fofana
    Lama Siblany
    Deborah Eshagh
    Olivier Adotevi
    Caroline Laheurte
    Laure Ricard
    Rémy Dulery
    Nicolas Stocker
    Zoe van de Wyngaert
    Alexis Genthon
    Anne Banet
    Mara Memoli
    Souhila Ikhlef
    Simona Sestilli
    Anne Vekhof
    Eolia Brissot
    Zora Marjanovic
    Yannick Chantran
    Nancy Cuervo
    Eric Ballot
    Laurence Morand-Joubert
    Mohamad Mohty
    Blood Cancer Journal, 11
  • [48] IMMUNOGENICITY OF SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC LIVER DISEASE
    Hitawala, Asif
    Wright, Elizabeth
    Nee, Gavin
    Galvez, Graciela
    Gopalakrishna, Harish
    Mironova, Maria
    Franco, Gian Rodriguez
    Rotman, Yaron
    Heller, Theo
    Scott, Shani
    Rivero, Anna Liza
    De Giorgi, Valeria
    Porche, Sarah
    Saleem, Zillay
    Kalish, Heather
    Ricotta, Emily
    Ghany, Marc
    HEPATOLOGY, 2024, 80
  • [49] Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
    Saad-Roy, Chadi M.
    Morris, Sinead E.
    Metcalf, C. Jessica E.
    Mina, Michael J.
    Baker, Rachel E.
    Farrar, Jeremy
    Holmes, Edward C.
    Pybus, Oliver G.
    Graham, Andrea L.
    Levin, Simon A.
    Grenfell, Bryan T.
    Wagner, Caroline E.
    SCIENCE, 2021, 372 (6540) : 363 - 370
  • [50] Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series
    Sherman, Amy C.
    van Haren, Simon D.
    Borberg, Ella
    Swank, Zoe
    Aleissa, Muneerah
    Tong, Alexandra
    Rooks, Rebecca
    Kanwal, Urwah
    Levine, Hannah
    Yates, Bridget
    Izaguirre, Natalie
    Ryff, Kevin
    Thomas, Sanya
    Parisi, Lindsey
    Li, Xiaofang
    Walt, David R.
    Levy, Ofer
    Walsh, Stephen R.
    Issa, Nicolas C.
    Baden, Lindsey R.
    VACCINE, 2024, 42 (22)
12345